A phase I clinical trial found that oral NMN supplementation at 1,200 mg/day effectively increases NAD levels in both blood and brain tissue, with benefits requiring 2-4 weeks of sustained administration. The study showed once-daily dosing is sufficient and works equally well in healthy individuals and Parkinson’s patients. This provides clinical validation for NMN’s bioavailability and establishes evidence-based dosing protocols that practitioners can reference when prescribing Annular’s NMN product.
For your business
Clinical data now confirms that 1,200mg daily NMN reaches the brain and requires 2-4 weeks of consistent use for optimal NAD restoration in your patients.